Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Tax Provisions (2020 - 2021)

Historic Tax Provisions for Insight Molecular Diagnostics (IMDX) over the last 2 years, with Q4 2021 value amounting to -$97000.0.

  • Insight Molecular Diagnostics' Tax Provisions fell 16100.63% to -$97000.0 in Q4 2021 from the same period last year, while for Sep 2024 it was -$97000.0, marking a year-over-year change of. This contributed to the annual value of -$8.1 million for FY2022, which is 1290.32% up from last year.
  • Per Insight Molecular Diagnostics' latest filing, its Tax Provisions stood at -$97000.0 for Q4 2021, which was down 16100.63% from $1.8 million recorded in Q2 2021.
  • In the past 5 years, Insight Molecular Diagnostics' Tax Provisions registered a high of $1.8 million during Q2 2021, and its lowest value of -$7.6 million during Q1 2021.